Royal Bank of Canada cut its stake in Henry Schein Inc. (NASDAQ:HSIC) by 7.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 213,112 shares of the company’s stock after selling 17,702 shares during the period. Royal Bank of Canada owned about 0.26% of Henry Schein worth $37,679,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Regentatlantic Capital LLC acquired a new position in Henry Schein during the second quarter valued at approximately $984,000. Carroll Financial Associates Inc. boosted its position in Henry Schein by 294.9% in the second quarter. Carroll Financial Associates Inc. now owns 4,683 shares of the company’s stock valued at $827,000 after buying an additional 3,497 shares during the period. Eqis Capital Management Inc. boosted its position in Henry Schein by 23.4% in the second quarter. Eqis Capital Management Inc. now owns 1,639 shares of the company’s stock valued at $290,000 after buying an additional 311 shares during the period. Legacy Private Trust Co. boosted its position in Henry Schein by 37.9% in the second quarter. Legacy Private Trust Co. now owns 6,370 shares of the company’s stock valued at $1,126,000 after buying an additional 1,750 shares during the period. Finally, Capstone Asset Management Co. boosted its position in Henry Schein by 11.2% in the second quarter. Capstone Asset Management Co. now owns 10,774 shares of the company’s stock valued at $1,905,000 after buying an additional 1,089 shares during the period. Institutional investors and hedge funds own 93.43% of the company’s stock.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Shares of Henry Schein Inc. (NASDAQ:HSIC) traded down 1.21% during trading on Friday, hitting $156.96. The stock had a trading volume of 1,382,512 shares. The stock has a market cap of $12.63 billion, a price-to-earnings ratio of 26.06 and a beta of 1.09. Henry Schein Inc. has a one year low of $142.64 and a one year high of $183.00. The stock’s 50-day moving average price is $155.84 and its 200 day moving average price is $167.17.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Wednesday, November 2nd. The company reported $1.68 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.65 by $0.03. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. The company earned $2.87 billion during the quarter, compared to analysts’ expectations of $2.88 billion. During the same period in the prior year, the company earned $1.55 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities analysts forecast that Henry Schein Inc. will post $6.58 EPS for the current year.

Several research analysts recently commented on the company. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, August 8th. Goldman Sachs Group Inc. raised Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective for the company in a report on Tuesday, October 11th. Robert W. Baird reissued an “outperform” rating and issued a $176.00 price objective (up from $175.00) on shares of Henry Schein in a report on Tuesday, October 4th. Bank of America Corp. began coverage on Henry Schein in a report on Monday, September 12th. They issued a “buy” rating and a $185.00 price objective for the company. Finally, Leerink Swann reissued a “hold” rating on shares of Henry Schein in a report on Thursday, November 3rd. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Henry Schein has a consensus rating of “Hold” and a consensus price target of $172.83.

In related news, EVP Mark E. Mlotek sold 2,417 shares of the stock in a transaction dated Thursday, November 3rd. The shares were sold at an average price of $155.19, for a total value of $375,094.23. Following the completion of the sale, the executive vice president now owns 40,456 shares in the company, valued at $6,278,366.64. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Paul Brons sold 3,381 shares of the stock in a transaction dated Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the completion of the sale, the director now owns 13,715 shares of the company’s stock, valued at approximately $2,249,671.45. The disclosure for this sale can be found here. Company insiders own 1.27% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.